Ocuphire Pharma Total Current Liabilities 2010-2024 | IRD
Ocuphire Pharma total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| Ocuphire Pharma Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $4 |
| 2022 | $3 |
| 2021 | $4 |
| 2020 | $3 |
| 2019 | $9 |
| 2018 | $3 |
| 2017 | $3 |
| 2016 | $2 |
| 2015 | $3 |
| 2014 | $2 |
| 2013 | $1 |
| 2012 | $1 |
| 2011 | $1 |
| 2010 | $2 |
| 2009 | $1 |
| Ocuphire Pharma Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $4 |
| 2024-03-31 | $6 |
| 2023-12-31 | $4 |
| 2023-09-30 | $4 |
| 2023-06-30 | $6 |
| 2023-03-31 | $4 |
| 2022-12-31 | $3 |
| 2022-09-30 | $3 |
| 2022-06-30 | $3 |
| 2022-03-31 | $3 |
| 2021-12-31 | $4 |
| 2021-09-30 | $3 |
| 2021-06-30 | $3 |
| 2021-03-31 | $2 |
| 2020-12-31 | $3 |
| 2020-09-30 | $3 |
| 2020-06-30 | $3 |
| 2020-03-31 | $2 |
| 2019-12-31 | $9 |
| 2019-09-30 | $3 |
| 2019-06-30 | $4 |
| 2019-03-31 | $3 |
| 2018-12-31 | $3 |
| 2018-09-30 | $3 |
| 2018-06-30 | $3 |
| 2018-03-31 | $3 |
| 2017-12-31 | $3 |
| 2017-09-30 | $2 |
| 2017-06-30 | $2 |
| 2017-03-31 | $2 |
| 2016-12-31 | $2 |
| 2016-09-30 | $2 |
| 2016-06-30 | $2 |
| 2016-03-31 | $3 |
| 2015-12-31 | $3 |
| 2015-09-30 | $3 |
| 2015-06-30 | $3 |
| 2015-03-31 | $3 |
| 2014-12-31 | $2 |
| 2014-09-30 | $2 |
| 2014-06-30 | $2 |
| 2014-03-31 | $1 |
| 2013-12-31 | $1 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $1 |
| 2012-12-31 | $1 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $1 |
| 2011-12-31 | $1 |
| 2011-09-30 | $4 |
| 2011-06-30 | $4 |
| 2011-03-31 | $3 |
| 2010-12-31 | $2 |
| 2010-09-30 | $1 |
| 2010-06-30 | $2 |
| 2010-03-31 | $1 |
| 2009-12-31 | $1 |
| 2009-09-30 | $0 |
| 2009-06-30 | $1 |
| 2009-03-31 | $0 |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fanhua (AIFU) | China | $0.086B | 2.07 |
| Top KingWin (WAI) | China | $0.008B | 0.00 |
| S&W Seed (SANW) | United States | $0.006B | 0.00 |
| Invo BioScience (NAYA) | United States | $0.004B | 0.00 |